{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Codeine+Sulfate&page=2", "query": { "intervention": "Codeine Sulfate", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Codeine+Sulfate&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-10T15:10:10.553Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01010139", "title": "Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Codeine Sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 18, "start_date": "2006-08", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01010139" }, { "nct_id": "NCT02958566", "title": "Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Colon Cancer", "Colon Diverticulosis", "Colonic Neoplasms", "Colonic Diverticulitis", "Pain, Postoperative", "Ileus", "Ileus Paralytic", "Ileus; Mechanical", "Constipation Drug Induced", "Constipation", "Rectum Cancer", "Rectum Neoplasm" ], "interventions": [ { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Orphenadrine", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Marcaine", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" }, { "name": "Methadone", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Morphine Sulfate", "type": "DRUG" }, { "name": "Fentanyl", "type": "DRUG" }, { "name": "Dilaudid", "type": "DRUG" }, { "name": "Hydrocodone-Acetaminophen Tab 5-325 MG", "type": "DRUG" }, { "name": "HYDROCODONE/ACETAMINOPHEN 5 Mg-325 Mg ORAL TABLET", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Illinois College of Medicine at Peoria", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2017-01", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2017-03-20", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 1, "location_summary": "Peoria, Illinois", "locations": [ { "city": "Peoria", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02958566" }, { "nct_id": "NCT01010152", "title": "Comparative Bioavailability Study of Codeine Sulfate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Codeine Sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 34, "start_date": "2008-01", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01010152" }, { "nct_id": "NCT03317730", "title": "Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Locally Advanced Head and Neck Cancer" ], "interventions": [ { "name": "Xtampza ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 28, "start_date": "2018-05-01", "completion_date": "2020-11-17", "has_results": false, "last_update_posted_date": "2021-07-20", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03317730" }, { "nct_id": "NCT00818493", "title": "Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Q8003 (morphine sulfate and oxycodone hydrochloride)", "type": "DRUG" }, { "name": "Low dose Q8003 (morphine sulfate and oxycodone hydrochloride)", "type": "DRUG" }, { "name": "Percocet (oxycodone and acetaminophen)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "QRxPharma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2009-02", "completion_date": "2009-07", "has_results": false, "last_update_posted_date": "2012-05-17", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 4, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Royal Oak, Michigan + 1 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Royal Oak", "state": "Michigan" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00818493" }, { "nct_id": "NCT03564548", "title": "Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cancer", "Breakthrough Cancer Pain" ], "interventions": [ { "name": "PPP001", "type": "DRUG" }, { "name": "Morphine sulfate or Hydromorphone or Oxycodone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tetra Bio-Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2021-05-26", "completion_date": "2022-04", "has_results": false, "last_update_posted_date": "2021-07-28", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 1, "location_summary": "Berlin, New Jersey", "locations": [ { "city": "Berlin", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03564548" }, { "nct_id": "NCT01280331", "title": "Comparison of the Safety of Q8003 Versus Morphine Equivalent Doses of Its Components (Oxycodone and Morphine) in Bunionectomy Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Q8003 (morphine sulfate and oxycodone hydrochloride)", "type": "DRUG" }, { "name": "Morphine sulfate", "type": "DRUG" }, { "name": "Oxycodone HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "QRxPharma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 375, "start_date": "2011-01", "completion_date": "2011-04", "has_results": false, "last_update_posted_date": "2012-05-17", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 4, "location_summary": "Anaheim, California • Owings Mills, Maryland • Pasadena, Maryland + 1 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Owings Mills", "state": "Maryland" }, { "city": "Pasadena", "state": "Maryland" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01280331" }, { "nct_id": "NCT02858310", "title": "E7 TCR T Cells for Human Papillomavirus-Associated Cancers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Papillomavirus Infections", "Cervical Intraepithelial Neoplasia", "Carcinoma In Situ", "Vulvar Neoplasms", "Vulvar Diseases" ], "interventions": [ { "name": "E7 TCR cells", "type": "BIOLOGICAL" }, { "name": "Aldesleukin", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "EKG", "type": "DIAGNOSTIC_TEST" }, { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Chest CT and MRI or PET", "type": "DIAGNOSTIC_TEST" }, { "name": "PFT", "type": "DIAGNOSTIC_TEST" }, { "name": "Granisetron", "type": "DRUG" }, { "name": "Ondansetron", "type": "DRUG" }, { "name": "Droperidol", "type": "DRUG" }, { "name": "Prochlorperazine", "type": "DRUG" }, { "name": "Diphenoxylate HCL", "type": "DRUG" }, { "name": "Atropine sulfate", "type": "DRUG" }, { "name": "Codeine sulfate", "type": "DRUG" }, { "name": "Loperamide", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Diphenhydramine HCL", "type": "DRUG" }, { "name": "Hydroxyzine HCL", "type": "DRUG" }, { "name": "Meperidine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "DIAGNOSTIC_TEST", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 224, "start_date": "2017-01-27", "completion_date": "2025-07-02", "has_results": true, "last_update_posted_date": "2026-03-09", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 2, "location_summary": "Bethesda, Maryland • New Brunswick, New Jersey", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02858310" }, { "nct_id": "NCT01009853", "title": "Steady State Study of Codeine Sulfate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Codeine Sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roxane Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 34, "start_date": "2008-01", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01009853" }, { "nct_id": "NCT03088826", "title": "Analgesic Efficacy of (MSIR)/Acetaminophen vs. Oxycodone/Acetaminophen (Percocet)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain Management" ], "interventions": [ { "name": "Morphine Sulfate", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Antonios Likourezos", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 80, "start_date": "2017-08-18", "completion_date": "2020-12-22", "has_results": true, "last_update_posted_date": "2022-03-14", "last_synced_at": "2026-09-10T15:10:10.553Z", "location_count": 1, "location_summary": "Brooklyn, New York", "locations": [ { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03088826" } ] }